PRESCRIBING INFORMATION

Similar documents
Package leaflet: Information for the user. HYDROCORTISON CUM CHLORAMPHENICOL 5 mg/g + 2 mg/g eye ointment hydrocortisone acetate, chloramphenicol

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

PRODUCT INFORMATION CHLORSIG

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

Minims Chloramphenicol

The active component of CHLOROMYCETIN eye ointment is chloramphenicol.

SUMMARY OF PRODUCT CHARACTERISTICS

A first-line treatment for ear infections in children with ear tubes*

PRESCRIBING INFORMATION AND PATIENT MEDICATION INFORMATION

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED on behalf of NHS Fife by:

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Please call the Pharmacy Medicines Unit on or for a copy.

PRESCRIBING INFORMATION AND PATIENT MEDICATION INFORMATION VIADERM K.C. CREAM

B. PACKAGE LEAFLET 1

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

Unshakeable confidence

SUMMARY OF PRODUCT CHARACTERISTICS

Author of PGD: Adrian MacKenzie, Lead Pharmacist, Community Pharmacy.

ADVANTAGE FOR DOGS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

Summary of Product Characteristics

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

B. PACKAGE LEAFLET 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Metacam 1.5 mg/ml oral suspension for dogs

= 0.5 mg. In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1.

This drug SHOULD NOT be used in: XXPregnant or nursing animals. XXDogs that are weak, old, or frail.

LABELLING AND PACKAGE LEAFLET A. LABELLING

ADVANTAGE FOR CATS

GENTAMICIN SULFATE- gentamicin sulfate solution/ drops Pacific Pharma, Inc GENTAMICIN SULFATE ophthalmic s olution, USP 0.

Kirkland Signature Minoxidil Topical Solution USP, 5% Drug Facts

SUMMARY OF PRODUCT CHARACTERISTICS

SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5% UNDER THE MINOR AILMENT SERVICE

SUMMARY OF PRODUCT CHARACTERISTICS

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5% UNDER THE MINOR AILMENT SERVICE

SAMPLE NOT FOR SALE 8 Weeks and Older and 9 lbs. and Under 1 Pack x 20 x 145

LABELLING AND PACKAGE LEAFLET

Summary of Product Characteristics

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION. Ciprofloxacin Ophthalmic Solution, USP 0.3% w/v (as ciprofloxacin hydrochloride)

SUMMARY OF PRODUCT CHARACTERISTICS

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

SUMMARY OF PRODUCT CHARACTERISTICS. Animeloxan 1.5 mg/ml oral suspension for dogs. Active substance: Meloxicam 1.5 mg (equivalent to 0.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Dry Eye Keratoconjunctivitis sicca (KCS)

large dog 5-way protection against: fleas/ticks/biting flies/mosquitoes/lice WARNING pack flea & tick protection KEEP OUT OF REACH OF CHILDREN

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

USA Product Label

[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Irish Medicines Board

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS

New Zealand Consumer Medicine Information

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Use to regrow hair on the top of the scalp (vertex only, see pictures on side of this carton)

Summary of Product Characteristics

WARNING KEEP OUT OF REACH OF CHILDREN DO NOT USE ON CATS. Code: pvasmmd

Other ingredients are sodium chloride and purified water.

Starts working through contact

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION N HYDROmorphone HP 10

SUMMARY OF PRODUCT CHARACTERISTICS. Procaine penicillin Dihydrostreptomycin Sulfate

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

extra large dog 5-way protection 3 pack extra large dog WARNING extra large dog flea & tick protection over 55 lbs KEEP OUT OF REACH OF CHILDREN pack

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (HYDROmorphone Hydrochloride) Sterile Solution for Injection

FRONTLINE TOP SPOT FOR CATS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PREFURRED PLUS For Dogs

SUMMARY OF PRODUCT CHARACTERISTICS / LABELLING

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/33

Submission for Reclassification

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

EPA Est. No IL-001. Assurity and Elanco. EPA Reg. No

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

for For use ONLY on cats 8 weeks and Older and Weighing 5 to 9 lbs. for CATS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

SUMMARY OF PRODUCT CHARACTERISTICS

medium dog 5-way protection 3 pack medium dog WARNING medium dog flea & tick protection KEEP OUT OF REACH OF CHILDREN pack lbs DO NOT USE ON CATS

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

Transcription:

PRESCRIBING INFORMATION Pr PENTAMYCETIN Chloramphenicol Ophthalmic Solution USP 0.25%, 0.5% Chloramphenicol Ophthalmic Ointment USP 1% Antibiotic Pr PENTAMYCETIN/HC Chloramphenicol and Hydrocortisone Eye and Ear Suspension (chloramphenicol 0.2% and hydrocortisone acetate 1%) Chloramphenicol and Hydrocortisone Eye and Ear Ointment (chloramphenicol 1% and hydrocortisone acetate 1%) Antibiotic/Corticosteroid Sandoz Canada Inc. 145 Jules-Léger Date of Revision: June 14, 2018 Boucherville, QC, Canada J4B 7K8 Submission control number: 214703

Pr PENTAMYCETIN Chloramphenicol Ophthalmic Solution USP 0.25%, 0.5% Chloramphenicol Ophthalmic Ointment USP 1% Antibiotic Pr PENTAMYCETIN/HC Chloramphenicol and Hydrocortisone Eye and Ear Suspension (chloramphenicol 0.2% and hydrocortisone acetate 1%) Chloramphenicol and Hydrocortisone Eye and Ear Ointment (chloramphenicol 1% and hydrocortisone acetate 1%) Antibiotic/Corticosteroid INDICATIONS AND CLINICAL USE PENTAMYCETIN, Ophthalmic Solution and Ointment Treatment of superficial ocular infections involving the conjunctiva and/or the cornea, caused by microorganisms shown by bacteriological studies to be susceptible to chloramphenicol. PENTAMYCETIN/HC, Eye and Ear Suspension and Ointment For topical use in superficial ocular and auditory infections, such as non-purulent conjunctivitis and otitis externa, caused by microorganisms shown by bacteriological studies to be susceptible to chloramphenicol. Hydrocortisone acetate has anti-inflammatory effects. To reduce the development of drug-resistant bacteria and maintain the effectiveness of PENTAMYCETIN & PENTAMYCETIN/HC and other antibacterial drugs, PENTAMYCETIN & PENTAMYCETIN/HC should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. WARNINGS Bone marrow hypoplasia, including aplastic anemia and death, has been reported following local application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agent would be expected to Pentamycetin and Pentamycetin/HC Page 2 of 13

provide effective treatment. Susceptibility/Resistance Development of Drug Resistant Bacteria Prescribing PENTAMYCETIN or PENTAMYCETIN/HC in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and risks the development of resistant organisms. Potential for Microbial Overgrowth The prolonged use of chloramphenicol may occasionally result in overgrowth of non-susceptible microorganisms including fungi. If new infection occur, discontinue use and institute alternative therapy. CONTRAINDICATIONS Sensitivity to chloramphenicol with signs of local irritation, symptoms of burning, angioneurotic edema, itching, urticaria, vesicular and maculopapular dermatitis. If these signs appear, withdraw the medication and consult your physician. Hypersensitivity to any components of the medication. PENTAMYCETIN/HC Suspension and Ointment are especially contraindicated in epithelial herpes simplex, keratitis, vaccina, varicella, viral diseases of the cornea and conjunctiva, tuberculosis of the eye; fungal diseases of the eye, acute purulent untreated infections of the eye, which, like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid. PRECAUTIONS AND ADVERSE REACTIONS It should be borne in mind that a patient may become sensitized to chloramphenicol when it is applied topically. Extended ophthalmic use of corticosteroid drugs may cause increased intraocular pressure in certain individuals and in those diseases causing thinning of the cornea or sclera, perforation has been known to occur. It is recommended that intraocular pressure be checked frequently. Safety of the use of corticosteroids during pregnancy has not been substantiated. In all serious infections, the topical use of chloramphenicol should be supplemented by appropriate systemic medication. Pentamycetin and Pentamycetin/HC Page 3 of 13

DOSAGE AND ADMINISTRATION PENTAMYCETIN, Ophthalmic Solutions 2 drops of the ophthalmic solution to the affected eye(s) every 3 hours or more often if necessary. PENTAMYCETIN Ophthalmic Ointment A small amount of ointment to the affected eye(s) every 3 hours or more often if necessary. PENTAMYCETIN/HC, Eye and Ear Suspension 2 drops to the affected eye(s) or into the affected ear(s) every 3 hours or more often if necessary. PENTAMYCETIN/HC, Eye and Ear Ointment A small amount of ointment to the affected eye(s) or into the affected ear(s) every 3 hours or more often if necessary. Decrease the frequency after 48 hours; the treatment should be continued at least 48 hours after the affected eyes (the affected ears) return to normal. OVERDOSAGE For management of a suspected drug overdose, contact your regional Poison Control Centre immediately. DOSAGE FORMS, COMPOSITION AND PACKAGING; STORAGE AND STABILITY PENTAMYCETIN (Chloramphenicol Ophthalmic Solution USP 0.25%) 10 ml Each milliliter contains 2.5 mg (0.25%) of chloramphenicol and 0.5% chlorobutanol as preservative in a sterile buffered solution. Available in bottle with dropper. Refrigerate (2-8ºC) until dispensing. Protect from freezing. After dispensing, the solution may be stored at room temperature for 21 days; after that period, discard unused portion. Avoid contamination of the tip of the dropper. Do not use if the dropper-tip cap is detached from the security ring. PENTAMYCETIN (Chloramphenicol Ophthalmic Solution USP 0.5%) 10 ml Each milliliter contains 5 mg (0.5%) of chloramphenicol and 0.5% chlorobutanol as preservative in a sterile buffered solution. Available in bottle with dropper. Refrigerate (2-8ºC) until dispensing. Protect from freezing. After dispensing, the solution may be stored at room temperature for 21 days; after that period, discard unused portion. Avoid contamination of the tip of the dropper. Do not use if the dropper-tip cap is detached from the security ring. PENTAMYCETIN (Chloramphenicol Ophthalmic Ointment USP 1%) 3.5 g Pentamycetin and Pentamycetin/HC Page 4 of 13

Each gram contains 10 mg (1%) of chloramphenicol in a sterile petrolatum base. Available in collapsible tube. Avoid contamination of the tip of the tube. Store between 15 and 30ºC. Protect from freezing. PENTAMYCETIN/HC (Chloramphenicol 0.2% and Hydrocortisone Acetate 1% Eye and Ear Suspension) 5 ml Each milliliter contains 2 mg (0.2%) of chloramphenicol, 10 mg (1.0%) hydrocortisone acetate in a sterile buffered vehicle. Shake well before each use. Available in bottle with dropper. Refrigerate (2-8ºC) until dispensing. Protect from freezing. After dispensing, the solution may be stored at room temperature for 21 days; after that period, discard unused portion. Avoid contamination of the tip of the dropper. Do not use if the dropper-tip cap is detached from the security ring. PENTAMYCETIN/HC (Chloramphenicol 1% and Hydrocortisone Acetate 1% Eye and Ear Ointment) 3.5 g Each gram contains 10 mg (1%) of chloramphenicol and 10 mg (1%) hydrocortisone acetate in a sterile petrolatum base. Available in collapsible tube. Avoid contamination of the tip of the tube. Store between 15 and 30ºC. Protect from freezing. Pentamycetin and Pentamycetin/HC Page 5 of 13

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Read this carefully before you start taking PENTAMYCETIN each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about PENTAMYCETIN. What is PENTAMYCETIN used for? PENTAMYCETIN is used to treat infections in the eye. Antibacterial drugs like PENTAMYCETIN treat only bacterial infections. They do not treat viral infections. How Does PENTAMYCETIN work? PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria What are the ingredients in PENTAMYCETIN? Ophthalmic Solution: Medicinal ingredients: Chloramphenicol. Non-medicinal ingredients: chlorobutanol as preservative, polyethylene glycol, polyoxyethylene stearate, water for injection and hydrochloride acid or sodium hydroxide to adjust ph. Ophthalmic Ointment Medicinal ingredients: Chloramphenicol. Non-medicinal ingredients: petrolatum base PENTAMYCETIN comes in the following dosage forms: Pentamycetin (Ophthalmic Solution 0.25% and 0.5%): Bottle of 10 ml Pentamycetin (Ophthalmic Ointment 1%): Tube of 3.5 g Do not use PENTAMYCETIN if: you are allergic to chloramophenicol or to any of the other ingredients in PENTAMYCETIN. To help avoid side effects and ensure proper use, talk to your healthcare professional before you take PENTAMYCETIN. Talk about any health conditions or problems you may have, including if you: experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists, consult a physician; Pentamycetin and Pentamycetin/HC Page 6 of 13

Other warnings you should know about: Overuse of this product may produce increased redness of the eye; Do not touch tip of tube to any surface to avoid contamination. If there is no improvement within two days of starting treatment, stop use and consult a physician. Your vision may be blurred for a few minutes after using the product. Do not drive or operate machinery until you can see clearly; Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines. How to take PENTAMYCETIN: Although you may feel better early in treatment, PENTAMYCETIN should be used exactly as directed. Misuse or overuse of PENTAMYCETIN could lead to the growth of bacteria that will not be killed by PENTAMYCETIN (resistance). This means that PENTAMYCETIN may not work for you in the future. Do not share your medicine. How do I use PENTAMYCETIN Ointment? Apply a small amount of ointment to the affected eye or eyes, every 3 hours or more often if necessary. Applying PENTAMYCETIN Ointment into the eye: Wash hands with soap and water. Sit in front of a mirror so you can see what you are doing. Take the lid off the ointment. Tilt your head back. Gently pull down your lower eyelid and look up. Hold the tube above the eye and gently squeeze a 1cm line of ointment along the inside of the lower eyelid, taking care not to touch the eye or eyelashes with the tip of the tube. Blink your eyes to spread the ointment over the surface of the eyeball. Your vision may be blurred when you open your eyes - DON'T rub your eyes. The blurring will clear after a few moments if you keep blinking. Wipe away any excess ointment with a clean tissue. Repeat this procedure for the other eye if you have been advised to do so by your doctor or pharmacist. Replace the cap on the tube. Take care not to touch the tip of the tube with your fingers. Contact lenses should not be worn until the infection has resolved. How do I use PENTAMYCETIN Ophthalmic Solution? Instill 2 drops to the affected eye every 3 hours or more often if necessary. Applying PENTAMYCETIN Ophthalmic Solution into the eye: Wash hands with soap and water. Pentamycetin and Pentamycetin/HC Page 7 of 13

Tilt the head back or lie down and look toward the ceiling. With the eyes open, gently pull the lower eyelid below the eyelashes away from the eye to form a pouch. Hold the bottle at least 2 cm away and squeeze one drop into the pouch. Slowly release the lower lid. Gently close the eye for one or two minutes. Do not rub the eye and try not to blink. If multiple drops are used, wait three to five minutes between each drop. Do not let the bottle directly touch the eye. Contact lenses should not be worn until the infection has resolved. Overdose: If you think you have taken too much PENTAMYCETIN, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms. What are possible side effects from using PENTAMYCETIN? These are not all the possible side effects you may feel when taking PENTAMYCETIN. If you experience any side effects not listed here, contact your healthcare professional. SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM Symptom / effect Talk to your healthcare professional Only if severe In all cases Stop taking drug and get immediate medical help Local irritation: symptoms of burning, swelling (angioneurotic edema), itching, hives (urticarial), rash (vesicular and maculopapular dermatitis) If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional. Pentamycetin and Pentamycetin/HC Page 8 of 13

Reporting Side Effects You can report any suspected side effects associated with the use of health products to Health Canada by: Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhpmps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or Calling toll-free at 1-866-234-2345. NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. Storage: PENTAMYCETIN (Ophthalmic Solution 0.25% and 0.5%): Refrigerate (2-8ºC) until dispensing. Protect from freezing. After dispensing, the solution may be stored at room temperature for 21 days; after that period, discard unused portion. Avoid contamination of the tip of the dropper. Do not use if the dropper-tip cap is detached from the security ring. PENTAMYCETIN (Ophthalmic Ointment USP 1%): Store between 15 and 30ºC. Protect from freezing. Keep out of reach and sight of children. If you want more information about PENTAMYCETIN: Talk to your healthcare professional Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; the manufacturer s website www.sandoz.ca, or by calling 1-800-361-3062. This leaflet was prepared by Sandoz Canada Inc. Last Revised: June 14, 2018 Pentamycetin and Pentamycetin/HC Page 9 of 13

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Read this carefully before you start taking PENTAMYCETIN/HC each time you get a refill. This leaflet is a summary and will not tell you everything about this drug. Talk to your healthcare professional about your medical condition and treatment and ask if there is any new information about PENTAMYCETIN/HC. What is PENTAMYCETIN/HC used for? PENTAMYCETIN/HC is used to treat infections in the eye and ear. Antibacterial drugs like PENTAMYCETIN/HC treat only bacterial infections. They do not treat viral infections. How Does PENTAMYCETIN/HC work? PENTAMYCETIN/HC contains two medicines: chloramphenicol (antibiotic) that kills bacteria and stops it from growing. hydrocortisone acetate (corticosteroid) that prevents inflammation. What are the ingredients in PENTAMYCETIN/HC? Eye and Ear Suspension Medicinal ingredients: Chloramphenicol and Hydrocortisone Acetate Non-medicinal ingredients: povidone, polysorbate, water for injection and hydrochloride acid or sodium hydroxide to adjust ph. Eye and Ear Ointment Medicinal ingredients: Chloramphenicol and Hydrocortisone Acetate Non-medicinal ingredients: petrolatum base PENTAMYCETIN/HC comes in the following dosage forms: Pentamycetin/HC (Eye and Ear Suspension): Bottle of 5 ml Pentamycetin/HC (Eye and Ear Ointment): Tube of 3.5 g Do not use PENTAMYCETIN/HC if: you are allergic to chloramophenicol or to any of the other ingredients in PENTAMYCETIN. you have an inflamed cornea (front part of the eye), also known as keratitis. you have a viral or fungal infection in the eye. To help avoid side effects and ensure proper use, talk to your healthcare professional before you take PENTAMYCETIN/HC. Talk about any health conditions or problems you Pentamycetin and Pentamycetin/HC Page 10 of 13

may have, including if you: experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists, consult a physician; are pregnant or planning to become pregnant. Other warnings you should know about: Overuse of this product may produce increased redness of the eye; Do not touch tip of tube to any surface to avoid contamination. If there is no improvement within two days of starting treatment, stop use and consult a physician. your vision may be blurred for a few minutes after using the product. Do not drive or operate machinery until you can see clearly; How to take PENTAMYCETIN/HC: Although you may feel better early in treatment, PENTAMYCETIN/HC should be used exactly as directed. Misuse or overuse of PENTAMYCETIN/HC could lead to the growth of bacteria that will not be killed by PENTAMYCETIN/HC (resistance). This means that PENTAMYCETIN/HC may not work for you in the future. Do not share your medicine. How do I use PENTAMYCETIN/HC Ointment? Apply one application in the affected eye or ear, every 3 hours or more often if necessary. Applying PENTAMYCETIN/HC Ointment into the eye: Wash hands with soap and water. Sit in front of a mirror so you can see what you are doing. Take the lid off the ointment. Tilt your head back. Gently pull down your lower eyelid and look up. Hold the tube above the eye and gently squeeze a 1cm line of ointment along the inside of the lower eyelid, taking care not to touch the eye or eyelashes with the tip of the tube. Blink your eyes to spread the ointment over the surface of the eyeball. Your vision may be blurred when you open your eyes - DON'T rub your eyes. The blurring will clear after a few moments if you keep blinking. Wipe away any excess ointment with a clean tissue. Repeat this procedure for the other eye if you have been advised to do so by your doctor or pharmacist. Replace the cap on the tube. Take care not to touch the tip of the tube with your fingers. Contact lenses should not be worn until the infection has resolved. How do I use PENTAMYCETIN/HC Solution? Instill 2 drops to the affected eye or ear every 3 hours or more often if necessary. Applying PENTAMYCETIN/HC Solution into the eye: Pentamycetin and Pentamycetin/HC Page 11 of 13

Wash hands with soap and water. Tilt the head back or lie down and look toward the ceiling. With the eyes open, gently pull the lower eyelid below the eyelashes away from the eye to form a pouch. Hold the bottle at least 2 cm away and squeeze one drop into the pouch. Slowly release the lower lid. Gently close the eye for one or two minutes. Do not rub the eye and try not to blink. If multiple drops are used, wait three to five minutes between each drop. Do not let the bottle directly touch the eye. Contact lenses should not be worn until the infection has resolved. Administering PENTAMYCETIN/HC Solution or Ointment in the ear: Lie on the side or tilt the head over so that the infected ear is facing upwards. Gently pull the earlobe upwards, away from the neck, and squeeze the drops or a small amount of ointment into the ear. Let the drops flow against the side of the ear canal and gently massage the ear around the opening to help the drops work down. Keep the head tilted for a few minutes. Overdose: If you think you have taken too much PENTAMYCETIN/HC, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms. What are possible side effects from using PENTAMYCETIN/HC? These are not all the possible side effects you may feel when taking PENTAMYCETIN/HC. If you experience any side effects not listed here, contact your healthcare professional. SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM Symptom / effect Talk to your healthcare professional Only if severe In all cases Stop taking drug and get immediate medical help Local irritation: symptoms of burning, swelling (angioneurotic edema), itching, hives (urticarial), rash (vesicular and maculopapular dermatitis) Pentamycetin and Pentamycetin/HC Page 12 of 13

Reporting Side Effects You can report any suspected side effects associated with the use of health products to Health Canada by: Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhpmps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or Calling toll-free at 1-866-234-2345. NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. Storage: PENTAMYCETIN/HC (Eye and Ear Suspension): Refrigerate (2-8ºC) until dispensing. Protect from freezing. After dispensing, the solution may be stored at room temperature for 21 days; after that period, discard unused portion. Avoid contamination of the tip of the dropper. Do not use if the dropper-tip cap is detached from the security ring. PENTAMYCETIN/HC (Ointment): Store between 15 and 30ºC. Protect from freezing Keep out of reach and sight of children. If you want more information about PENTAMYCETIN/HC: Talk to your healthcare professional Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website; the manufacturer s website www.sandoz.ca, or by calling 1-800-361-3062. This leaflet was prepared by Sandoz Canada Inc. Last Revised: June 14, 2018 Pentamycetin and Pentamycetin/HC Page 13 of 13